EUCTR2007-003560-21-IT进行中（未招募）不适用
Prospective multicenter phase I-II pilot trial to evaluate efficacy and safety of treatment with Lenalidomide plus R-CHOP21 (LR-CHOP21) for elderly patients with untreated Diffuse Large B-Cell Lymphoma (DLBCL). - REAL07
GIMURE0 个研究点开始时间: 2007年10月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Histologic subtypes as follows: a. CD20 positive Diffuse large B-Cell lymphoma b. CD20 positive Follicular grade IIIb 2. Age 60-80 3. Measurable and/or evaluable disease. 4. Ann Arbor stage II, III, IV 5. International Prognostic Index at low-intermediate, intermediate, high risk (2/3/4-5) 5. Adequate haematological counts: ANC > 1.5 x 109/L and platelet count > 75 x 109/L unless due to bone marrow involvement 6. Conjugated bilirubin up to 2 x ULN. 7. Alkaline phosphatase and transaminases up to 2 x ULN.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Lymphoblastic Lymphoma 2. Burkitt Lymphoma 3. Non Hodgkin lymphoma CD 20 negative 4. Mantle Cell Lymphoma 5. Follicular Non Hodgkin Lymphoma grade I-II-IIIa 6. Primitive mediastinal diffuse large B cell lymphoma with only mediastinal involvement 7. International Prognostic Index at low risk (1) 8. Has known or suspected hypersensitivity or intolerance to rituximab 9. History of evolutive malignancy within the last 3 years other than squamous cell and basal cell carcinoma.
研究者
相似试验
进行中（未招募）
1 期
Study to assess the efficacy and safety of treatment with FOLFIRI-aflibercept compared to initial treatment with FOLFIRI-aflibercept (for 6 cycles) followed by maintenance with 5FU-aflibercept, in an elderly population with metastatic colorectal cancer after failure of an oxaliplatin-based regimeEUCTR2016-004076-21-ESGrupo de Tratamiento de los Tumores Digestivos (TTD)
进行中（未招募）
2 期
A Multi Centre, Pilot Phase II Trial Assessing The Efficacy And Safety Of Bevacizumab + Gemcitabine + Carboplatin As First Line Treatment For Patients Diagnosed With Triple Negative Metastatic Breast Cancer.CTRI/2010/091/001135Roche Products India Pvt Ltd44
进行中（未招募）
不适用
Trial that evaluates the combination treatment of Trabectedin and Radiotherapy in Soft Tissue Sarcoma patients.Soft Tissue SarcomaEUCTR2014-001549-26-ESGEIS96
进行中（未招募）
不适用
A phase 2, controlled, multi-center pilot study to evaluate the efficacy and safety of Deligoparin in subjects with retinal vein occlusion of recent onset.EUCTR2005-003374-24-ITOPOCRIN S.P.A.70
已完成
不适用
Virtual Care of Acute DiverticulitisAcute diverticulitisOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonInfection - Studies of infection and infectious agentsACTRN12621000692831Surgical Outcomes Research Centre, Royal Prince Alfred Hospital50